Meeting of the National Advisory Council for Healthcare Research and Quality, 29083 [2017-13393]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 122 / Tuesday, June 27, 2017 / Notices
these priority populations are
encouraged.
Sharon B. Arnold,
Deputy Director.
[FR Doc. 2017–13396 Filed 6–26–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces a meeting of the
National Advisory Council for
Healthcare Research and Quality.
DATES: The meeting will be held on
Wednesday, July 26, 2017, from 8:30
a.m. to 2:45 p.m.
ADDRESSES: The meeting will be held at
AHRQ, 5600 Fishers Lane, Rockville,
Maryland, 20857.
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A,
Rockville, Maryland 20857, (301) 427–
1456. For press-related information,
please contact Alison Hunt at (301) 427–
1244 or Alison.Hunt@ahrq.hhs.gov.
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
Wednesday, July 19, 2017. The agenda,
roster, and minutes will be available
from Ms. Bonnie Campbell, Committee
Management Officer, Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Rockville, Maryland
20857. Ms. Campbell’s phone number is
(301) 427–1554.
SUPPLEMENTARY INFORMATION:
SUMMARY:
mstockstill on DSK30JT082PROD with NOTICES
I. Purpose
The National Advisory Council for
Healthcare Research and Quality is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
VerDate Sep<11>2014
18:33 Jun 26, 2017
Jkt 241001
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
(B) the field of health care research
including training needs and
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
II. Agenda
On Wednesday, July 26, 2017, there
will be a subcommittee meeting for the
National Healthcare Quality and
Disparities Report scheduled to begin at
7:30 a.m. This meeting is open to the
public. The Council meeting will
convene at 8:30 a.m., with the call to
order by the Council Chair and approval
of previous Council summary notes. The
meeting is open to the public and will
be available via webcast at
www.webconferences.com/ahrq. The
meeting will begin with an update on
AHRQ’s current research, programs, and
initiatives. The agenda will also include
an update on AHRQ’s work in learning
health care systems and AHRQ’s
EvidenceNOW initiative, and will focus
on the use of AHRQ data and analytics
to answer emerging policy questions.
The final agenda will be available on the
AHRQ Web site at www.AHRQ.gov no
later than Wednesday, July 19, 2017.
Sharon B. Arnold,
Deputy Director.
[FR Doc. 2017–13393 Filed 6–26–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Drug Therapy for Early
Rheumatoid Arthritis in Adults—An
Update
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review of
Drug Therapy for Early Rheumatoid
Arthritis in Adults—An Update, which
is currently being conducted by the
SUMMARY:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
29083
AHRQ’s Evidence-based Practice
Centers (EPC) Program. Access to
published and unpublished pertinent
scientific information will improve the
quality of this review.
DATES: Submission Deadline on or
before July 27, 2017.
ADDRESSES: Email submissions:
SEADS@epc-src.org.
Print submissions:
Mailing Address: Portland VA
Research Foundation, Scientific
Resource Center, ATTN: Scientific
Information Packet Coordinator, P.O.
Box 69539, Portland, OR 97239.
Shipping Address (FedEx, UPS, etc.):
Portland VA Research Foundation,
Scientific Resource Center, ATTN:
Scientific Information Packet
Coordinator, 3710 SW U.S. Veterans
Hospital Road, Mail Code: R&D 71,
Portland, OR 97239.
FOR FURTHER INFORMATION CONTACT:
Ryan McKenna, Telephone: 503–220–
8262 ext. 51723 or Email: SEADS@epcsrc.org.
SUPPLEMENTARY INFORMATION: AHRQ is
conducting this systematic review
pursuant to Section 902(a) of the Public
Health Service Act, 42 U.S.C. 299a(a).
The Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Drug Therapy for Early
Rheumatoid Arthritis in Adults—An
Update.
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Drug Therapy for Early
Rheumatoid Arthritis in Adults—An
Update, including those that describe
adverse events. The entire research
protocol, including the key questions, is
also available online at: https://effective
healthcare.ahrq.gov/search-for-guidesreviews-and-reports/?pageaction=
displayproduct&productID=2475.
This is to notify the public that the
EPC Program would find the following
information on Drug Therapy for Early
Rheumatoid Arthritis in Adults—An
Update helpful:
D A list of completed studies that
your organization has sponsored for this
indication. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov,
E:\FR\FM\27JNN1.SGM
27JNN1
]]>Agencies
[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Page 29083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13393]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Meeting of the National Advisory Council for Healthcare Research
and Quality
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces a meeting of the National Advisory Council for
Healthcare Research and Quality.
DATES: The meeting will be held on Wednesday, July 26, 2017, from 8:30
a.m. to 2:45 p.m.
ADDRESSES: The meeting will be held at AHRQ, 5600 Fishers Lane,
Rockville, Maryland, 20857.
FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management
Official, at the Agency for Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427-
1456. For press-related information, please contact Alison Hunt at
(301) 427-1244 or Alison.Hunt@ahrq.hhs.gov.
If sign language interpretation or other reasonable accommodation
for a disability is needed, please contact the Food and Drug
Administration (FDA) Office of Equal Employment Opportunity and
Diversity Management on (301) 827-4840, no later than Wednesday, July
19, 2017. The agenda, roster, and minutes will be available from Ms.
Bonnie Campbell, Committee Management Officer, Agency for Healthcare
Research and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms.
Campbell's phone number is (301) 427-1554.
SUPPLEMENTARY INFORMATION:
I. Purpose
The National Advisory Council for Healthcare Research and Quality
is authorized by Section 941 of the Public Health Service Act, 42
U.S.C. 299c. In accordance with its statutory mandate, the Council is
to advise the Secretary of the Department of Health and Human Services
and the Director of AHRQ on matters related to AHRQ's conduct of its
mission including providing guidance on (A) priorities for health care
research, (B) the field of health care research including training
needs and information dissemination on health care quality and (C) the
role of the Agency in light of private sector activity and
opportunities for public private partnerships. The Council is composed
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.
II. Agenda
On Wednesday, July 26, 2017, there will be a subcommittee meeting
for the National Healthcare Quality and Disparities Report scheduled to
begin at 7:30 a.m. This meeting is open to the public. The Council
meeting will convene at 8:30 a.m., with the call to order by the
Council Chair and approval of previous Council summary notes. The
meeting is open to the public and will be available via webcast at
www.webconferences.com/ahrq. The meeting will begin with an update on
AHRQ's current research, programs, and initiatives. The agenda will
also include an update on AHRQ's work in learning health care systems
and AHRQ's EvidenceNOW initiative, and will focus on the use of AHRQ
data and analytics to answer emerging policy questions. The final
agenda will be available on the AHRQ Web site at www.AHRQ.gov no later
than Wednesday, July 19, 2017.
Sharon B. Arnold,
Deputy Director.
[FR Doc. 2017-13393 Filed 6-26-17; 8:45 am]
BILLING CODE 4160-90-P
